Cap

Zacks Small Cap Research – MGRM: Monogram Receives Clearance from the FDA on its 510(k) Submission for its mBôs TKA System. – Go Health Pro

by

By Thomas Kerr, CFA NASDAQ:MGRM READ THE FULL MGRM RESEARCH REPORT On March 17, 2025, Monogram (NASDAQ:MGRM) announced that the FDA has granted 510(k) clearance for its Monogram mBôs TKA System. This determination means that the company can move forward with upgrades and begin the commercialization process. The mBôs TKA System is designed to deliver … Read more

Zacks Small Cap Research – MDAI: Burn Study Topline Data – Go Health Pro

by
Zacks Small Cap Research – MDAI: Burn Study Topline Data – Go Health Pro

By John Vandermosten, CFA NASDAQ:MDAI READ THE FULL MDAI RESEARCH REPORT Spectral AI, Inc. (NASDAQ:MDAI) reported topline data from its burn validation study in a March 17th press release confirming DeepView’s superior detection sensitivity relative to burn physicians. The announcement reminded stakeholders of the device’s background and development along with a description of the burn study’s … Read more

Zacks Small Cap Research – TELO Study Shows Cancer-Related Breakthrough – Go Health Pro

by

By Brad Sorensen, CFA NASDAQ:TELO READ THE FULL TELO RESEARCH REPORT Telomir Pharmaceuticals (NASDAQ:TELO) is a preclinical stage biopharmaceutical company developing a product designed to lengthen the DNA’s protective telomere caps. Previously reported preclinical tests have shown evidence that Telomir-1, the company’s primary therapy, can lengthen telomeres and initial animal testing illustrates the potential impact. … Read more

Zacks Small Cap Research – CBAT: Reasons for optimism are on the horizon as the company discusses new expansion plans. – Go Health Pro

by

By Brian Lantier, CFA NASDAQ:CBAT READ THE FULL CBAT RESEARCH REPORT CBAK Energy Reports Full Year 2024 Results On Monday, March 17th, CBAK Energy Technology (NASDAQ:CBAT) released its full-year results which saw many of the trends of 2024 continue into the fourth quarter including profound weakness in the raw material business. While we will have … Read more

Zacks Small Cap Research – SDOT: Sadot Group Reports 2024 Financial Results Which Showed the First Full Year Positive Net Income in the Company’s History – Go Health Pro

by

By Thomas Kerr, CFA NASDAQ:SDOT READ THE FULL SDOT RESEARCH REPORT 4th Quarter and Full Year 2024 Financial Results On March 11, 2025, Sadot Group (NASDAQ:SDOT) reported 4th quarter and full year 2024 results which showed continued strength in the commodity trading business. In the latest filings, the restaurant operations have been reported as discontinued … Read more

x